Not yet recruiting
Clear cell renal cell carcinoma
Not yet recruitingPhase I study of 161Tb-PSMA-1 therapy and gallium‑68 gozetotide imaging in adult patients with metastatic clear cell renal cell carcinoma
Registered drugNo placebo
Phase I study of 161Tb-PSMA-1 therapy and gallium‑68 gozetotide imaging in adult patients with metastatic clear cell renal cell carcinoma
Registered drugNo placebo
- Disease:Clear cell renal cell carcinoma
- Substances:GozetotidePSMA 1
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Gozetotide
